ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,226Medicare Part D Prescriptions Filled, Including Refills
$702K Total Retail Price of All Prescriptions
683 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 693 649
SIMVASTATIN 571 544
METFORMIN HCL 361 325
AMLODIPINE BESYLATE 337 307
LEVOTHYROXINE SODIUM 309 303
HYDROCODONE-ACETAMINOPHEN 287 196 S3
PRAVASTATIN SODIUM 216 196
LOSARTAN POTASSIUM 213 209
OMEPRAZOLE 190 168
LOVASTATIN 186 177
METOPROLOL TARTRATE 175 165
ATORVASTATIN CALCIUM 163 145
HYDROCHLOROTHIAZIDE 141 124
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 130
TAMSULOSIN HCL 134 134
ATENOLOL 128 126
METOPROLOL SUCCINATE 121 108
FUROSEMIDE 111 102
FINASTERIDE 111 111
SERTRALINE HCL 110 96
ZOLPIDEM TARTRATE 109 102
FLUTICASONE PROPIONATE 107 105
WARFARIN SODIUM 98 93
POTASSIUM CHLORIDE 98 89
ALENDRONATE SODIUM 89 82
GABAPENTIN 85 70
RANITIDINE HCL 81 70
ALLOPURINOL 79 73
GLIMEPIRIDE 79 74
CRESTOR 74 74
SPIRIVA 73 69
SPIRONOLACTONE 72 57
TERAZOSIN HCL 71 71
CITALOPRAM HBR 69 67
PANTOPRAZOLE SODIUM 68 65
ESCITALOPRAM OXALATE 68 60
CARVEDILOL 68 63
ADVAIR DISKUS 59 51
BENAZEPRIL HCL 58 54
TRIAMTERENE-HCTZ 55 55
DIOVAN 51 51
ZETIA 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.